Incidence of infectious complications following transrectal ultrasound-guided prostate biopsy in Calgary, Alberta, Canada: A retrospective population-based analysis

Rudzinski, J; Kawakami, Jun

doi:10.5489/cuaj.1751

Cited by 25 publications

(19 citation statements)

References 34 publications

(54 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In that study, the incidence rate of infectious complications was 4.2%. Another retrospective study of 927 patients who underwent TRUS-guided prostate biopsy from January 2012 to July 2012 also examined the incidence rate of complications [11]. In that study, the incidence rate of infectious complications was 4.1%, which was similar to our finding (3.8%).…”

Section: Discussionsupporting

confidence: 86%

Complications of Transrectal Ultrasound-Guided Prostate Biopsy: Impact of Prebiopsy Enema

et al. 2014

View full text Add to dashboard Cite

PurposeTransrectal ultrasound (TRUS)-guided biopsy of the prostate is usually safe. However, some patients are hospitalized owing to complications from TRUS biopsy. We identified the risk factors for complications and effective preventive measures for treating complications after TRUS biopsy.Materials and MethodsMedical records and radiological images of 1,083 patients who underwent TRUS biopsy of the prostate over 10 years in Gyeongsang National University Hospital were examined retrospectively to investigate the correlation between complications after TRUS biopsy and preventive antibiotics, prebiopsy enema, number of biopsy cores, and pathological findings.ResultsComplications occurred in 69 patients (6.4%). The complication rates of the 1,008 patients who received antibiotics and the 75 patients who did not were 6.3% and 8.0%, respectively (p=0.469). Complication rates of the pre-biopsy enema group (n=658) and the group without prebiopsy enema (n=425) were 4.7% and 8.9%, respectively (p=0.007). Complication rates of the 6-core biopsy group (n=41) and the 12-core biopsy group (n=955) were 7.3% and 6.3%, respectively (p=0.891). Complication rates of the prostate cancer group (n=306) and the no prostate cancer group (n=713) were 6.2% and 6.6%, respectively (p=0.740).ConclusionsA prebiopsy enema was associated with a reduced risk of complications after TRUS biopsy. Preventive antibiotics, number of biopsy cores, and pathological findings did not significantly influence the complication rate.

show abstract

Section: Discussionsupporting

confidence: 86%

Complications of Transrectal Ultrasound-Guided Prostate Biopsy: Impact of Prebiopsy Enema

et al. 2014

View full text Add to dashboard Cite

show abstract

“…The most common source of bacteremia in adults is the urinary tract [ 17 ]. Between 2% and 6% of patients who undergo transrectal prostate biopsy develop infectious complications, which can include bacteremia [ 18 ]. In this population, fluoroquinolone-resistant ExPEC strains colonizing the rectum are the most common source of infections [ 19 ].…”

Section: E Coli Bacteremiamentioning

confidence: 99%

Extraintestinal PathogenicEscherichia coli, a Common Human Pathogen: Challenges for Vaccine Development and Progress in the Field

Poolman

Wacker²

2015

J Infect Dis.

210

157

View full text Add to dashboard Cite

Extraintestinal pathogenic Escherichia coli (ExPEC) is the most common gram-negative bacterial pathogen in humans. ExPEC causes the vast majority of urinary tract infections (UTIs), is a leading cause of adult bacteremia, and is the second most common cause of neonatal meningitis. Increasing multidrug resistance among ExPEC strains constitutes a major obstacle to treatment and is implicated in increasing numbers of hospitalizations and deaths and increasing healthcare costs associated with ExPEC infections. An effective vaccine against ExPEC infection is urgently needed. The O antigen, a component of the surface lipopolysaccharide, has been identified as a promising vaccine target. With the availability of a novel bioconjugation technology it is expected that multivalent O antigen conjugate vaccines can be produced at industrial scale. Clinical proof of concept of a 4-valent O antigen conjugate vaccine is ongoing. An ExPEC vaccine effective against strains that are associated with major diseases and resistant to multiple drugs could be routinely delivered to individuals at risk of developing severe E. coli infection, such as elderly people, individuals undergoing abdominal surgery and prostatic biopsy procedures, and persons at risk of recurrent and/or complicated UTI.

show abstract

“…One of the highest risks of getting a multi‐resistance BSI after prostate biopsy is travel from or to developing countries in their previous 12 months . This has been a problem, which is documented not only in Australia but also in UK, Canada and elsewhere.…”

Section: Global Food Trade and Travel As Vehicles To Acquire Resistanmentioning

confidence: 99%

Antibiotic resistance: are we all doomed?

Collignon

2015

Internal Medicine Journal

View full text Add to dashboard Cite

Antibiotic resistance is a growing and worrying problem associated with increased deaths and suffering for people. Overall, there are only two factors that drive antimicrobial resistance, and both can be controlled. These factors are the volumes of antimicrobials used and the spread of resistant micro-organisms and/or the genes encoding for resistance. The One Health concept is important if we want to understand better and control antimicrobial resistance. There are many things we can do to better control antimicrobial resistance. We need to prevent infections. We need to have better surveillance with good data on usage patterns and resistance patterns available across all sectors, both human and agriculture, locally and internationally. We need to act on these results when we see either inappropriate usage or resistance levels rising in bacteria that are of concern for people. We need to ensure that food and water sources do not spread multi-resistant micro-organisms or resistance genes. We need better approaches to restrict successfully what and how antibiotics are used in people. We need to restrict the use of 'critically important' antibiotics in food animals and the entry of these drugs into the environment. We need to ensure that 'One Health' concept is not just a buzz word but implemented. We need to look at all sectors and control not only antibiotic use but also the spread and development of antibiotic resistant bacteria -both locally and internationally.

show abstract

Incidence of infectious complications following transrectal ultrasound-guided prostate biopsy in Calgary, Alberta, Canada: A retrospective population-based analysis

Cited by 25 publications

References 34 publications

Complications of Transrectal Ultrasound-Guided Prostate Biopsy: Impact of Prebiopsy Enema

Complications of Transrectal Ultrasound-Guided Prostate Biopsy: Impact of Prebiopsy Enema

Extraintestinal PathogenicEscherichia coli, a Common Human Pathogen: Challenges for Vaccine Development and Progress in the Field

Antibiotic resistance: are we all doomed?

Contact Info

Product

Resources

About